2 terminated, 1 completed, 1 unknown. 2 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Zai Lab (Hong Kong), Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis ZL-1102 1% w/w gel BID for 16 weeks, ZL-1102 3% w/w gel BID for 16 weeks, ZL-1102 3% w/w gel QD for 16 weeks - Plaque Psoriasis | Phase 2 | Terminated | Zai Lab (Hong Kong), Ltd. | 65 | 2024-05-22 | 2026-08-10 |
| A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers Moxifloxacin Oral Tablet, Omadacycline Oral Tablet - Healthy Volunteer | Phase 1 | Completed | Zai Lab (Hong Kong), Ltd. | 24 | 2024-04-16 | 2024-11-01 |
| A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP Omadacycline, Moxifloxacin - Community-acquired Bacterial Pneumonia | Phase 3 | Unknown | Zai Lab (Hong Kong), Ltd. | 100 | 2023-11-17 | 2024-06-14 |
| A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors ZL-1218, Pembrolizumab - Malignant Solid Tumor | Phase 1 | Terminated | Zai Lab (Hong Kong), Ltd. | 34 | 2023-07-24 | 2025-10-20 |
Moxifloxacin (2) · omadacycline (2) · pembrolizumab (1)
China (3) · Australia (1) · Spain (1) · United States (1)
Haihui Huang, PhD (1) · Jian Liu (1) · Yonghong Xiao (1)